IRIS
TENNI, RUGGERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.490
EU - Europa 1.150
AS - Asia 721
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
OC - Oceania 2
SA - Sud America 2
Totale 3.374
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.487
CN - Cina 701
IE - Irlanda 375
UA - Ucraina 209
FI - Finlandia 152
IT - Italia 118
DE - Germania 105
SE - Svezia 64
GB - Regno Unito 60
BE - Belgio 28
FR - Francia 25
IR - Iran 11
RU - Federazione Russa 8
A2 - ???statistics.table.value.countryCode.A2??? 5
JP - Giappone 4
CA - Canada 3
MU - Mauritius 3
AU - Australia 2
IN - India 2
NL - Olanda 2
RO - Romania 2
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
EU - Europa 1
MD - Moldavia 1
MY - Malesia 1
TR - Turchia 1
Totale 3.374
Salva come PNG Salva come JPEG
Città #
Dublin 375
Chandler 370
Jacksonville 236
Nanjing 184
Ann Arbor 120
Beijing 115
Ashburn 100
Nanchang 78
Shenyang 69
Lawrence 57
Medford 57
Princeton 57
Changsha 54
Wilmington 54
Hebei 43
Helsinki 41
Tianjin 36
Boardman 35
Jiaxing 32
Milan 31
Pavia 30
Hangzhou 29
Woodbridge 29
Brussels 28
Shanghai 28
Verona 19
Los Angeles 14
New York 12
Fairfield 9
Norwalk 9
Washington 9
Auburn Hills 8
Dearborn 8
Houston 8
Ningbo 6
Ardabil 5
Des Moines 5
Falkenstein 5
Seattle 5
Changchun 4
Jinan 4
Zanjan 4
Duncan 3
Falls Church 3
Monmouth Junction 3
San Giuliano Milanese 3
Zhengzhou 3
Andover 2
Augusta 2
Cambridge 2
Kunming 2
Maranello 2
Nakano 2
Pune 2
St Petersburg 2
Tappahannock 2
Teano 2
Toronto 2
Austin 1
Berlin 1
Borås 1
Chisinau 1
Council Bluffs 1
Cupertino 1
Edmonton 1
Ercolano 1
Gazipur 1
Genova 1
Guangzhou 1
Kuala Lumpur 1
Logan 1
Montereale Valcellina 1
Moscow 1
Orange 1
Piscataway 1
Reghin 1
Sacramento 1
Southend 1
Taganrog 1
Taizhou 1
Voronezh 1
Totale 2.482
Salva come PNG Salva come JPEG
Nome #
Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue 102
Conformational analysis and stability of collagen peptides by CD and by 1H- and 13C-NMR spectroscopies. 91
Stability and networks of hydrogen bonds of the collagen triple helical structure: influence of pH and chaotropic nature of three anions. 89
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 88
A de novo G to T transversion in a pro-a1(I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. 82
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 78
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 77
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 74
Platelet interaction with CNBr peptides from type II collagen via integrin alpha2 beta1 74
Extracellular matrix structure and nano-mechanics determine megakaryocyte function 73
Collagen fibril structure is affected by collagen concentration and decorin 72
Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen 72
Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. 71
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 71
Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. 70
Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms. 69
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. 67
A Mn(II)-Mn(II) center in human prolidase 66
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta. 66
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin 66
A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women. 63
Severe nonlethal osteogenesis imperfecta: biochemical heterogeneity. 63
Lack of prolidase causes a bone phenotype both in human and in mouse 63
Stability of type I collagen peptide trimers. 62
Effect of the triterpenoid fraction of Centella asiatica on macromolecules of the connective matrix in human skin fibroblast cultures. 62
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 61
The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant. 61
Self-aggregation of fibrillar collagens I and II involves lysine side chains. 61
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia 59
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 58
Fibromodulin interactions with type I and II collagens. 58
Effect of an oral calcium load on urinary markers of collagen breakdown. 57
Osteogenesis imperfecta mutations may probe vital functional domains (e.g. proteoglycan binding sites) of type I collagen fibrils. 56
EXTRACELLULAR MATRIX NANO-MECHANICS DETERMINE MEGAKARYOCITE FUNCTION. 56
Type I collagen CNBr peptides: species and behavior in solution 55
Mapping Hsp47-binding site(s) using CNBr peptides derived from type I and II collagen 53
Hypothesis on the role of hydroxylysyl glycosides in collagen fibre organization. 53
Comparison between urinary pyridinium cross-links and hydroxylysine glycosides in monitoring the effects of ovariectomy and 17b-estradiol replacement in aged rats. 53
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 52
Extracellular matrix nano-mechanics determines megakaryocyte function 52
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. 50
Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis. 50
Prolidase deficiency in two siblings with chronic leg ulcerations. Clinical, biochemical, and morphologic aspects. 49
Endogenous fibronectin modulates collagen-dependent spreading and proplatelet formation by human megakaryocytes 48
Pre-column derivatisation method for the measurement of glycosylated hydroxylysines of collagenous proteins. 47
Identifying the structure of the active sites of human recombinant prolidase 47
Calorimetric, biochemical and morphological investigations to validate a restoration method of fire injured ancient parchment. 47
Gly85 to Val substitution in proa1(I) chain causes mild osteogenesis imperfecta and introduces a susceptibility to protease digestion. 46
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 46
Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta. 45
Decorin transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC. 44
"In vitro" fibril formation of type I collagen from different sources: biochemical and morphological aspects. 43
Molecular stability of chemically modified collagen triple helices 43
Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine a1(I) 901 substitution in a type-I collagen gene. 38
The structure of extracellular matrices influences proplatelet formation by human megakaryocyte 37
Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens. 36
Moderately severe osteogenesis imperfecta: biochemical studies showing variable defect localization in the triple-helical domain of type I collagen. 34
Totale 3.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.657
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 5 0
2019/2020854 236 304 2 40 3 40 7 55 7 86 74 0
2020/2021371 52 35 9 42 2 42 7 58 12 53 48 11
2021/2022299 9 4 11 9 6 4 8 16 17 11 52 152
2022/20231.012 84 97 7 81 106 99 1 62 419 8 25 23
2023/2024335 52 69 13 29 28 88 13 23 4 13 3 0
Totale 3.426